Clinical Trial Update: Surveillance of Emerging Pathogens to Ensure Blood Supply Safety

View source ↗

Summary

A Canadian Blood Services–sponsored clinical trial on surveillance of emerging pathogens to safeguard the blood supply has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Babesiosis

Snippet

Sponsor: Canadian Blood Services | Conditions: Babesioses, Human | Status: WITHDRAWN